CCL2 and juvenile myelomonocytic leukemia: PBMCs from 2 patients with JMML driven by somatic PTPN11 variants also produced large amounts of inflammatory cytokines, particularly CCL2, although the levels of these molecules were lower than those in most CBL-LOH patients (Figure 2A).